| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $65.5M | — | +17.4% |
| Cost of Revenue | $18.0M | — | +13.2% |
| Gross Profit | $47.5M | — | +19.0% |
| R&D Expense | $10.8M | — | -3.0% |
| SG&A Expense | $14.0M | — | -4.0% |
| Operating Income | -$6.0M | — | +35.4% |
| Income Tax | $102K | — | +42.9% |
| Net Income | -$5.8M | — | +34.6% |
| EPS (Basic) | -$0.07 | — | +41.7% |
| EPS (Diluted) | -$0.07 | — | +41.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $42.2M | -23.2% | -21.0% |
| Accounts Receivable | $4.6M | +6.7% | +48.1% |
| Current Assets | $100.7M | -4.1% | -16.3% |
| Total Assets | $204.3M | -1.8% | +8.5% |
| Current Liabilities | $81.1M | -4.2% | +7.9% |
| Total Liabilities | $121.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.7M | — | -2505.0% |
| Capital Expenditures | $521K | — | +17.3% |
| Investing Cash Flow | -$5.0M | — | -322.9% |
| Financing Cash Flow | -$2.0M | — | -792.4% |
| Free Cash Flow | -$6.2M | — | -839.1% |
| +1.1% |
| Stockholders' Equity | $83.3M | +1.1% | +21.4% |